Orthogonal factors vs. interdependent variables as predictors of drug treatment response in anxious outpatients.
作者信息
Downing R W, Rickels K, Dreesmann H
出版信息
Psychopharmacologia. 1973;32(2):93-111. doi: 10.1007/BF00428681.
PMID:4584949
Abstract
摘要
相似文献
1
Orthogonal factors vs. interdependent variables as predictors of drug treatment response in anxious outpatients.
Psychopharmacologia. 1973;32(2):93-111. doi: 10.1007/BF00428681.
2
Setting, patient, and doctor effects on drug response in neurotic patients. II. Differential improvement.
Psychopharmacologia. 1970;18(2):209-26. doi: 10.1007/BF00401501.
3
Setting, patient, and doctor effects on drug response in neurotic patients. I. Differential attrition, dosage deviation, and side reaction responses to treatment.
Psychopharmacologia. 1970;18(2):180-208. doi: 10.1007/BF00401500.
4
Predictors of chlordiazepoxide response in anxiety.
Clin Pharmacol Ther. 1971 Mar-Apr;12(2):263-73. doi: 10.1002/cpt1971122part1263.
5
Six-week trial with diazepam: some clinical observations.
J Clin Psychiatry. 1985 Nov;46(11):470-4.
6
Evaluating clinical improvement in anxious outpatients: a comparison of normal and treated neurotic patients.评估焦虑门诊患者的临床改善情况：正常神经质患者与接受治疗的神经质患者的比较。
Am J Psychiatry. 1972 Feb;128(8):1005-9. doi: 10.1176/ajp.128.8.1005.
7
Clomacran in anxious neurotic outpatients: a controlled study.
J Clin Pharmacol New Drugs. 1972 Jan;12(1):46-53. doi: 10.1002/j.1552-4604.1972.tb00035.x.
8
Target symptoms: a promising improvement criterion in psychiatric drug research.
Arch Gen Psychiatry. 1968 May;18(5):595-600. doi: 10.1001/archpsyc.1968.01740050083014.
9
Hydroxyzine and chlordiazepoxide in anxious neurotic outpatients: a collaborative controlled study.
Compr Psychiatry. 1970 Sep;11(5):457-74. doi: 10.1016/0010-440x(70)90006-4.
10
A placebo-controlled, double-blind comparison of clobazam and diazepam in the treatment of anxiety.氯巴占与地西泮治疗焦虑症的安慰剂对照双盲比较
J Clin Psychiatry. 1983 Aug;44(8):296-300.
本文引用的文献
1
Symptom changes associated with improvement in schizophrenia.
J Consult Psychol. 1967 Apr;31(2):175-80. doi: 10.1037/h0020995.
2
The relationship of clinical symptoms and IPAT-factored tests of anxiety, regression and asthenia: a factor analytic study.
J Nerv Ment Dis. 1968 Feb;146(2):147-60. doi: 10.1097/00005053-196802000-00006.
3
The physician questionnaire: a useful tool in psychiatric drug research.
Psychopharmacologia. 1970;17(4):338-44. doi: 10.1007/BF00404239.
4
Previous medication, duration of illness and placebo response.
J Nerv Ment Dis. 1966 Jun;142(6):548-54. doi: 10.1097/00005053-196606000-00006.
5
Verbal ability (intelligence) and improvement in drug therapy of neurotic patients.
J New Drugs. 1965 Sep-Oct;5(5):303-7. doi: 10.1002/j.1552-4604.1965.tb00251.x.
6
Setting, patient, and doctor effects on drug response in neurotic patients. II. Differential improvement.
Psychopharmacologia. 1970;18(2):209-26. doi: 10.1007/BF00401501.
7
Setting, patient, and doctor effects on drug response in neurotic patients. I. Differential attrition, dosage deviation, and side reaction responses to treatment.
Psychopharmacologia. 1970;18(2):180-208. doi: 10.1007/BF00401500.
8
Predictors of chlordiazepoxide response in anxiety.
Clin Pharmacol Ther. 1971 Mar-Apr;12(2):263-73. doi: 10.1002/cpt1971122part1263.
9
Patient personality and demographic factors as predictors of early response to psychotropic drug treatment.
Compr Psychiatry. 1970 Nov;11(6):568-75.
10
Controlled comparison of SK&F 14336 and chlorpromazine in newly admitted schizophrenics.
J Clin Pharmacol J New Drugs. 1969 Sep-Oct;9(5):328-38.
Zotero 插件